Binding of Akkermansia muciniphila to mucin is O-glycan specific.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 May 2024
Historique:
received: 05 11 2023
accepted: 09 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 29 5 2024
Statut: epublish

Résumé

The intestinal anaerobic bacterium Akkermansia muciniphila is specialized in the degradation of mucins, which are heavily O-glycosylated proteins that constitute the major components of the mucus lining the intestine. Despite that adhesion to mucins is considered critical for the persistence of A. muciniphila in the human intestinal tract, our knowledge of how this intestinal symbiont recognizes and binds to mucins is still limited. Here, we first show that the mucin-binding properties of A. muciniphila are independent of environmental oxygen concentrations and not abolished by pasteurization. We then dissected the mucin-binding properties of pasteurized A. muciniphila by use of a recently developed cell-based mucin array that enables display of the tandem repeats of human mucins with distinct O-glycan patterns and structures. We found that A. muciniphila recognizes the unsialylated LacNAc (Galβ1-4GlcNAcβ1-R) disaccharide selectively on core2 and core3 O-glycans. This disaccharide epitope is abundantly found on human colonic mucins capped by sialic acids, and we demonstrated that endogenous A. muciniphila neuraminidase activity can uncover the epitope and promote binding. In summary, our study provides insights into the mucin-binding properties important for colonization of a key mucin-foraging bacterium.

Identifiants

pubmed: 38811534
doi: 10.1038/s41467-024-48770-8
pii: 10.1038/s41467-024-48770-8
doi:

Substances chimiques

Mucins 0
Polysaccharides 0
Neuraminidase EC 3.2.1.18
Disaccharides 0
Epitopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4582

Subventions

Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research)
ID : 737.016.003
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research)
ID : 024.002.002
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research)
ID : Spinoza Grant Willem M de Vos
Organisme : Federation of European Microbiological Societies (FEMS)
ID : FEMS-GO-2021-069
Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : 0071658
Organisme : Lundbeckfonden (Lundbeck Foundation)
ID : NA
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : GlycoSkin H2020-ERC; 772735

Informations de copyright

© 2024. The Author(s).

Références

Johansson, M. E., Sjövall, H. & Hansson, G. C. The gastrointestinal mucus system in health and disease. Nat. Rev. Gastroenterol. Hepatol. 10, 352–361 (2013).
pubmed: 23478383 pmcid: 3758667 doi: 10.1038/nrgastro.2013.35
Corfield, A. P. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochim. Biophys. Acta (BBA) - Gen. Subj. 1850, 236–252 (2015).
doi: 10.1016/j.bbagen.2014.05.003
Nilsson, H. E. et al. Intestinal MUC2 mucin supramolecular topology by packing and release resting on D3 domain assembly. J. Mol. Biol. 426, 2567–2579 (2014).
pubmed: 24816392 pmcid: 4293034 doi: 10.1016/j.jmb.2014.04.027
Sonnenburg, J. L., Angenent, L. T. & Gordon, J. I. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat. Immunol. 5, 569–573 (2004).
pubmed: 15164016 doi: 10.1038/ni1079
McLoughlin, K., Schluter, J., Rakoff-Nahoum, S., Smith, AdrianL. & Foster, KevinR. Host selection of microbiota via differential adhesion. Cell Host Microbe 19, 550–559 (2016).
pubmed: 27053168 doi: 10.1016/j.chom.2016.02.021
Tailford, L. E., Crost, E. H., Kavanaugh, D. W. & Juge, N. Mucin glycan foraging in the human gut microbiome. Front. Genet. 6, 81 (2015).
pubmed: 25852737 pmcid: 4365749 doi: 10.3389/fgene.2015.00081
Sonnenburg, J. L. et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307, 1955–1959 (2005).
pubmed: 15790854 doi: 10.1126/science.1109051
Derrien, M. et al. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1, 254–268 (2010).
pubmed: 21327032 pmcid: 3023607 doi: 10.4161/gmic.1.4.12778
Taleb, V. et al. Structural and mechanistic insights into the cleavage of clustered O-glycan patches-containing glycoproteins by mucinases of the human gut. Nat. Commun. 13, 4324 (2022).
pubmed: 35882872 pmcid: 9325726 doi: 10.1038/s41467-022-32021-9
Medley, B. J. et al. A previously uncharacterized O-glycopeptidase from Akkermansia muciniphila requires the Tn-antigen for cleavage of the peptide bond. J. Biol. Chem. 298, 102439 (2022).
pubmed: 36049519 pmcid: 9513282 doi: 10.1016/j.jbc.2022.102439
Belzer, C. et al. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B 12 production by intestinal symbionts. mBio 8, e00770–00717 (2017).
pubmed: 28928206 pmcid: 5605934 doi: 10.1128/mBio.00770-17
Cani, P. D. & de Vos, W. M. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front. Microbiol. 8, 1765–1765 (2017).
pubmed: 29018410 pmcid: 5614963 doi: 10.3389/fmicb.2017.01765
Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013).
pubmed: 23671105 pmcid: 3670398 doi: 10.1073/pnas.1219451110
Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103 (2019).
pubmed: 31263284 pmcid: 6699990 doi: 10.1038/s41591-019-0495-2
Plovier, H. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107–113 (2017).
pubmed: 27892954 doi: 10.1038/nm.4236
Depommier, C. et al. Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice. Gut Microbes 11, 1231–1245 (2020).
pubmed: 32167023 pmcid: 7524283 doi: 10.1080/19490976.2020.1737307
Reunanen, J. et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl. Environ. Microbiol. 81, 3655–3662 (2015).
pubmed: 25795669 pmcid: 4421065 doi: 10.1128/AEM.04050-14
Earley, H. et al. A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis. PLoS ONE 10, e0135280 (2015).
pubmed: 26491870 pmcid: 4619660 doi: 10.1371/journal.pone.0135280
Becken, B. et al. Genotypic and phenotypic diversity among human isolates of Akkermansia muciniphila. mBio https://doi.org/10.1128/mBio.00478-21 (2021).
Smith, T. J. et al. A mucin-regulated adhesin determines the spatial organization and inflammatory character of a bacterial symbiont in the vertebrate gut. Cell Host Microbe 31, 1371–1385.e1376 (2023).
pubmed: 37516109 doi: 10.1016/j.chom.2023.07.003
Karlsson, N. G., Nordman, H., Karlsson, H., Carlstedt, I. & Hansson, G. C. Glycosylation differences between pig gastric mucin populations: a comparative study of the neutral oligosaccharides using mass spectrometry. Biochem J. 326, 911–917 (1997).
pubmed: 9307045 pmcid: 1218750 doi: 10.1042/bj3260911
Nordman, H. et al. Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution. Biochem. J. 364, 191–200 (2002).
pubmed: 11988092 pmcid: 1222561 doi: 10.1042/bj3640191
Robbe, C., Capon, C., Coddeville, B. & Michalski, J. C. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem. J. 384, 307–316 (2004).
pubmed: 15361072 pmcid: 1134114 doi: 10.1042/BJ20040605
Robbe, C. et al. Evidence of regio-specific glycosylation in human intestinal mucins: presence of an acidic gradient along the intestinal tract *. J. Biol. Chem. 278, 46337–46348 (2003).
pubmed: 12952970 doi: 10.1074/jbc.M302529200
Nason, R. et al. Display of the human mucinome with defined O-glycans by gene engineered cells. Nat. Commun. 12, 4070 (2021).
pubmed: 34210959 pmcid: 8249670 doi: 10.1038/s41467-021-24366-4
Konstantinidi, A. et al. Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells. J. Biol. Chem. 298, 101784 (2022).
pubmed: 35247390 pmcid: 8980628 doi: 10.1016/j.jbc.2022.101784
van der Ark, K. C. H. et al. Model-driven design of a minimal medium for Akkermansia muciniphila confirms mucus adaptation. Micro. Biotechnol. 11, 476–485 (2018).
doi: 10.1111/1751-7915.13033
Ouwerkerk, J. P. et al. Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Appl. Environ. Microbiol. 82, 6983–6993 (2016).
pubmed: 27663027 pmcid: 5103097 doi: 10.1128/AEM.01641-16
Co, J. Y. et al. Mucins trigger dispersal of Pseudomonas aeruginosa biofilms. NPJ Biofilms Microbiomes 4, 23 (2018).
pubmed: 30323945 pmcid: 6180003 doi: 10.1038/s41522-018-0067-0
Robbe-Masselot, C. et al. Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. J. Proteome Res. 8, 702–711 (2009).
pubmed: 19152289 doi: 10.1021/pr800740j
Xia, L. Core 3-derived O-glycans are essential for intestinal mucus barrier function. Methods Enzymol. 479, 123–141 (2010).
pubmed: 20816163 doi: 10.1016/S0076-6879(10)79007-8
Narimatsu, Y. et al. An atlas of human glycosylation pathways enables display of the human glycome by gene engineered cells. Mol. Cell 75, 394–407.e395 (2019).
pubmed: 31227230 pmcid: 6660356 doi: 10.1016/j.molcel.2019.05.017
de Haan, N. et al. In-Depth profiling of O-glycan isomers in human cells using C18 nanoliquid chromatography-mass spectrometry and glycogenomics. Anal. Chem. 94, 4343–4351 (2022).
pubmed: 35245040 pmcid: 8928149 doi: 10.1021/acs.analchem.1c05068
Lotan, R., Skutelsky, E., Danon, D. & Sharon, N. The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J. Biol. Chem. 250, 8518–8523 (1975).
pubmed: 811657 doi: 10.1016/S0021-9258(19)40790-4
Chandrasekaran, E. V. et al. Novel interactions of complex carbohydrates with peanut (PNA), Ricinus communis (RCA-I), Sambucus nigra (SNA-I) and wheat germ (WGA) agglutinins as revealed by the binding specificities of these lectins towards mucin core-2 O-linked and N-linked glycans and related structures. Glycoconj. J. 33, 819–836 (2016).
pubmed: 27318477 doi: 10.1007/s10719-016-9678-y
van Passel, M. W. et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 6, e16876 (2011).
pubmed: 21390229 pmcid: 3048395 doi: 10.1371/journal.pone.0016876
Anggara, K. et al. Direct observation of glycans bonded to proteins and lipids at the single-molecule level. Science 382, 219–223 (2023).
pubmed: 37824645 pmcid: 7615228 doi: 10.1126/science.adh3856
Capon, C., Maes, E., Michalski, J. C., Leffler, H. & Kim, Y. S. Sd(a)-antigen-like structures carried on core 3 are prominent features of glycans from the mucin of normal human descending colon. Biochem. J. 358, 657–664 (2001).
pubmed: 11577689 pmcid: 1222115 doi: 10.1042/bj3580657
Podolsky, D. K. Oligosaccharide structures of human colonic mucin. J. Biol. Chem. 260, 8262–8271 (1985).
pubmed: 4008490 doi: 10.1016/S0021-9258(17)39465-6
Larsson, J. M., Karlsson, H., Sjövall, H. & Hansson, G. C. A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology 19, 756–766 (2009).
pubmed: 19321523 doi: 10.1093/glycob/cwp048
Ottman, N. et al. Genome-scale model and omics analysis of metabolic capacities of akkermansia muciniphila reveal a preferential mucin-degrading lifestyle. Appl. Environ. Microbiol. https://doi.org/10.1128/aem.01014-17 (2017).
Tailford, L. E. et al. Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation. Nat. Commun. 6, 7624 (2015).
pubmed: 26154892 doi: 10.1038/ncomms8624
Huang, K. et al. Biochemical characterisation of the neuraminidase pool of the human gut symbiont Akkermansia muciniphila. Carbohydr. Res. 415, 60–65 (2015).
pubmed: 26340137 doi: 10.1016/j.carres.2015.08.001
Thomsson, K. A., Bäckström, M., Holmén Larsson, J. M., Hansson, G. C. & Karlsson, H. Enhanced detection of sialylated and sulfated glycans with negative ion mode nanoliquid chromatography/mass spectrometry at high pH. Anal. Chem. 82, 1470–1477 (2010).
pubmed: 20092260 doi: 10.1021/ac902602e
Nordman, H. et al. Mucus glycoproteins from pig gastric mucosa: identification of different mucin populations from the surface epithelium. Biochem. J. 15, 903–910 (1997).
Niv, Y., Byrd, J. C., Ho, S. B., Dahiya, R. & Kim, Y. S. Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int. J. Cancer 50, 147–152 (1992).
pubmed: 1728605 doi: 10.1002/ijc.2910500129
Lesuffleur, T. et al. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J. Cell Sci. 106, 771–783 (1993).
pubmed: 8308060 doi: 10.1242/jcs.106.3.771
Madunic, K. et al. Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype. Cell. Mol. Life Sci. 78, 337–350 (2021).
pubmed: 32236654 doi: 10.1007/s00018-020-03504-z
Juge, N. Microbial adhesins to gastrointestinal mucus. Trends Microbiol. 20, 30–39 (2012).
pubmed: 22088901 doi: 10.1016/j.tim.2011.10.001
Cohen, L. J. et al. Unraveling function and diversity of bacterial lectins in the human microbiome. Nat. Commun. 13, 3101 (2022).
pubmed: 35661736 pmcid: 9166713 doi: 10.1038/s41467-022-29949-3
Mello, L. V., Chen, X. & Rigden, D. J. Mining metagenomic data for novel domains: BACON, a new carbohydrate-binding module. FEBS Lett. 584, 2421–2426 (2010).
pubmed: 20416301 doi: 10.1016/j.febslet.2010.04.045
Larsbrink, J. et al. A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes. Nature 506, 498–502 (2014).
pubmed: 24463512 pmcid: 4282169 doi: 10.1038/nature12907
Nakjang, S., Ndeh, D. A., Wipat, A., Bolam, D. N. & Hirt, R. P. A novel extracellular metallopeptidase domain shared by animal host-associated mutualistic and pathogenic microbes. PLoS ONE 7, e30287 (2012).
pubmed: 22299034 pmcid: 3267712 doi: 10.1371/journal.pone.0030287
Cantarel, B. L. et al. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res. 37, D233–D238 (2009).
pubmed: 18838391 doi: 10.1093/nar/gkn663
Ottman, N. et al. Characterization of outer membrane proteome of Akkermansia muciniphila reveals sets of novel proteins exposed to the human intestine. Front. Microbiol. 7, 1157 (2016).
pubmed: 27507967 pmcid: 4960237 doi: 10.3389/fmicb.2016.01157
Luis, A. S. & Hansson, G. C. Intestinal mucus and their glycans: a habitat for thriving microbiota. Cell Host Microbe 31, 1087–1100 (2023).
pubmed: 37442097 doi: 10.1016/j.chom.2023.05.026
Shuoker, B. et al. Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria. Nat. Commun. 14, 1833 (2023).
pubmed: 37005422 pmcid: 10067855 doi: 10.1038/s41467-023-37533-6
Crouch, L. I. et al. Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown. Nat. Commun. 11, 4017 (2020).
pubmed: 32782292 pmcid: 7419316 doi: 10.1038/s41467-020-17847-5
Shon, D. J. et al. An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins. Proc. Natl Acad. Sci. USA 117, 21299–21307 (2020).
pubmed: 32817557 pmcid: 7474620 doi: 10.1073/pnas.2012196117
Malaker, S. A. et al. The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins. Proc. Natl Acad. Sci. USA 116, 7278–7287 (2019).
pubmed: 30910957 pmcid: 6462054 doi: 10.1073/pnas.1813020116
Guo, X. et al. Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diverisity, and global distribution in mammalian gut microbiotas. BMC Genomics 18, 800 (2017).
pubmed: 29047329 pmcid: 5648452 doi: 10.1186/s12864-017-4195-3
Ouwerkerk, J. P. et al. Comparative Genomics and Physiology of Akkermansia muciniphila Isolates from Human Intestine Reveal Specialized Mucosal Adaptation. Microorganisms https://doi.org/10.3390/microorganisms10081605 (2022).
Kirmiz, N. et al. Comparative genomics guides elucidation of vitamin B(12) biosynthesis in novel human-associated akkermansia strains. Appl. Environ. Microbiol. https://doi.org/10.1128/aem.02117-19 (2020).
Karcher, N. et al. Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly. Genome Biol. 22, 209 (2021).
pubmed: 34261503 pmcid: 8278651 doi: 10.1186/s13059-021-02427-7
Sun, L. et al. Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins. J. Biol. Chem. 298, 101382 (2022).
pubmed: 34954141 doi: 10.1016/j.jbc.2021.101382
Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469–1476 (2004).
pubmed: 15388697 doi: 10.1099/ijs.0.02873-0
Stams, A. J., Van Dijk, J. B., Dijkema, C. & Plugge, C. M. Growth of syntrophic propionate-oxidizing bacteria with fumarate in the absence of methanogenic bacteria. Appl. Environ. Microbiol. 59, 1114–1119 (1993).
pubmed: 16348912 pmcid: 202247 doi: 10.1128/aem.59.4.1114-1119.1993
Miller, R. S. & Hoskins, L. C. Mucin degradation in human colon ecosystems: Fecal population densities of mucin-degrading bacteria estimated by a “most probable number” method. Gastroenterology 81, 759–765 (1981).
pubmed: 7262520 doi: 10.1016/0016-5085(81)90503-5
Damerell, D. et al. The GlycanBuilder and GlycoWorkbench glycoinformatics tools: updates and new developments. Biol. Chem. 393, 1357–1362 (2012).
pubmed: 23109548 doi: 10.1515/hsz-2012-0135
Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543–d552 (2022).
pubmed: 34723319 doi: 10.1093/nar/gkab1038

Auteurs

Janneke Elzinga (J)

Laboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands. jelzinga@sund.ku.dk.
Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. jelzinga@sund.ku.dk.

Yoshiki Narimatsu (Y)

Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
GlycoDisplay ApS, Copenhagen, Denmark.

Noortje de Haan (N)

Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Henrik Clausen (H)

Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Willem M de Vos (WM)

Laboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Hanne L P Tytgat (HLP)

Laboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands. hanne.tytgat@wur.nl.
Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland. hanne.tytgat@wur.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH